human methylated 27k microarrays (Illumina Inc)
90
Structured Review
Illumina Inc
human methylated 27k microarrays
Human Methylated 27k Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+methylation+27k+microarray/human+methylated+27k+microarrays/pmc06964049-162-10-9
Average 90 stars, based on 1 article reviews
Human Methylated 27k Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+methylation+27k+microarray/human+methylated+27k+microarrays/pmc06964049-162-10-9
Average 90 stars, based on 1 article reviews
human methylated 27k microarrays - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Methylation:Article Title: Systems therapeutics analyses identify genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer Article Snippet: .. We repeated this procedure selecting for methylation markers assessed by Illumina Article Title: Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses Article Snippet: .. We repeated this procedure selecting for methylation markers assessed by Illumina Microarray:Article Title: Systems therapeutics analyses identify genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer Article Snippet: .. We repeated this procedure selecting for methylation markers assessed by Illumina Article Title: Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses Article Snippet: .. We repeated this procedure selecting for methylation markers assessed by Illumina other:Article Title: Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses Article Snippet: We repeated the procedure for markers assessed by |